期刊文献+

肾母细胞瘤中PTEN、MMP-7的检测 被引量:1

Detecting of PTEN and MMP-7 in nephroblastoma
下载PDF
导出
摘要 目的:检测肾母细胞瘤(nephrohlastoma,wilms tumor,WT)组织中PTEN和MMP_7中的表达。方法:用免疫组化方法检测12例瘤旁正常肾组织和42例WT组织中PTEN、MMP_7的表达。结果:PTEN在WT组织中的表达明显低于正常瘤旁肾组织(P<0.05)。PTEN的表达与性别、年龄和病理学分型无关(P>0.05),而与临床分期明显相关(P<0.05)。12例对照组织标本中MMP_7未见表达,42例WT组织标本中MMP_7在胞浆表达率54.21%。MMP_7在预后良好(favorable histological types,FH)组中的阳性表达率明显低于在预后不良(unfavorable histological types,UH)组中的阳性表达率(P<0.05);PTEN和MMP_7呈负相关。结论:联合检测WT组织中PTEN和MMP_7的表达,能更好评估WT的侵袭和转移等生物学行为,两者可作为判断WT侵袭性的标志物。 To detect the expression of PTEN and MMP-7 in nephroblastoma. Methods: With immunohistochemistry to detect the expression of PTEN and MMP-7 in 12 cases of normal renal tissues near the tumor and 42 cases of children nephroblastoma tissues. Results : Expression of PTEN was lower in nephroblastoma than that in normal renal tissues( P 〈 0.05). Expression of PTEN has no significant relativity with sex, age and pathologic types( P 〉 0.05). But significant relativity was found between PTEN and clinical stage( P 〈 0.05). There is no MMP-7 positive expression in 12 cases normal renal tissues, and 54.21% positive rate in 42 cases nephroblastoma tissues. There is a significant higher expression of MMP-7 in unfavorable histologic types nephroblastoma group than that of in favorable histologic types nephroblastoma group. A negative relativity was found between PTEN and MMP-7 in nephroblastoma tissues. Conclusion : United detecting of PTEN and MMP-7 in nephroblastoma tissues, maybe stance helpful to estimate the biological behavior of nephroblastoma, and they can be the signal substance of estimating nephroblastoma' s metastasis.
作者 庞艳丽
出处 《河南医学研究》 CAS 2006年第2期121-123,共3页 Henan Medical Research
关键词 肾母细胞瘤 PTEN MMP-7 检测 nephroblastoma PTEN MMP-7 detect
  • 相关文献

参考文献10

  • 1Myers Mp, Stolarov Jp, EngC, et al. P-TEN, the tumorsuppressor from human chromosome 10q23,is a dual-speci-fieity phosphatase[J]. Proc Natl Acad Sci USA, 1997,94(17) :9052-9057.
  • 2Sharrard RM, Maitland NJ. Phenotypic effects of overexpre-ssion of the MMACI gene in prostate epithelial cells[ J ]. Br J Cancer, 2000,83 (8) :1102-1109.
  • 3McMenamin ME, Soung P, Perera S, et al.Loss of PTEN expression in paraffin-embedded primary prostate cancer correlates with high gleason score and advanced stage[J]. Cancer Res, 1999,59(17) :4291-4296.
  • 4Mutter GI,, Lin MC, Fitzgerald JT,et al. Alterd PTEN expression as a diagnositic marker for the earliest endometrial precancers[J]. J Natl Cancer 1nst ,2000,92( 11 ) :924-930.
  • 5Cairns P, Evron E, okami K, et al. Point mutation and homozygous deletion of PTEN/MMACI in primary bladder cancers[J]. Oncogene, 1998, 16(24) :3215-3218.
  • 6Kondo K, Yao M, Kobayashi K,et al. PTEN/MMACI/TEPI mutations in human primary renal-cell carcinomas and renal carcinoma cell lines[J].Int J Cancer,2001,91(2) :219-224.
  • 7Crawford HC, Fingleton BM, Rudolph-Owen LA, et al, The metallopro-teinase matrilysin is a target of beta-catenin transactivation in intestinal tumors[J], Oncogene, 1999,18(18) :2883-2891.
  • 8Ougolkov AV, Yamahita K, Mai M, et al. Oncogenic beta-catenin and MMP-(matrilysin)cosegregate in late-stage clinical colon cancer[J]. Gastroenterology,2002,122( 1 ) :60-71.
  • 9Mitsiades N, Yu WH, Poulaki V, et al. Matrix metalloproteinase-7-mediated cleavage of fas ligand protects tumor cells from chemotherapeutic drug cytotoxicity [ J ].Canoer Res, 2001,61 ( 2 ) : 577 -581.
  • 10Noe V,Fingleton B,Jacobs KC,et al, Release of an invasion promoter Eeadherin fragment by matrilysin and stromelysin-I[J], J Cell Sci, 2001,114(1) :111-118.

同被引文献9

  • 1张波,王家祥.肾母细胞瘤组织中VEGF和PTEN的表达[J].实用诊断与治疗杂志,2005,19(3):189-190. 被引量:4
  • 2孙玮,高飞,张利宁.新的抑癌基因PDCD4最新研究进展[J].药物分析杂志,2007,27(7):1138-1141. 被引量:7
  • 3Fine B, Hodakoski C, Koujak S, et al. Activation of the PI3K Pathway in Cancer Through Inhibition of PTEN by Exchange Factor P-REX2a. Science,2009,325(9) : 1 261-1 265.
  • 4Grill C, Guelly C, Ebner B, et al. Loss of PTEN/MMAC1 activity is a rare and late event in the pathogenesis of nephroblastomas. Human Pathology,2010,41 (8) : 1 172-1 177.
  • 5Lankat-Buttgereit B, Goke R. Primer review: the tumour suppressor Pded4: recent advances in the elucidation of function and regulation. Biology of the Cell, 2009,101(10): 309-317.
  • 6Palamarchuk A, Efanov A, Maximov V, et al. Akt phosphorylates and regulates Pdcd4 tumor suppressor protein. Cancer Research,2005,65(24): 11 282-11 286.
  • 7Vikhreva PN, Shepelev MV, Korobko EV, et al. Pdcd4 tumor suppressor: properties, functions, and possible applications to oncology. Mol Gen Microbiol Virusol, 2010, (2) :3-11.
  • 8Mattei P.小儿外科指南.李龙,主译.上海:第二军医大学出版社,2006.641-650.
  • 9孙艳花,钟雪云.PTEN与信号转导及肿瘤[J].中国病理生理杂志,2002,18(3):326-329. 被引量:7

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部